Search Results

0 results for ''Weil Gotshal Manges''

You can use to get even better search results
Appellate Division, First Department: March 28, 2024
Publication Date: 2024-03-28
Practice Area: Civil Appeals | Criminal Appeals
Industry:
Court: Appellate Division, First Department, Appeals & Motions
Judge: Unsigned
Attorneys:
For plaintiff:
For defendant:
Case number: DOCKET

Appeals & Motions List released on:March 26, 2024

March 27, 2024 | The American Lawyer

Freshfields the Latest to Move to 4 Days in US Offices

U.S. partners, associates, legal assistants and other fee earners at Freshfields will be expected to work at least four days in the office each week, beginning May 1.
2 minute read
March 27, 2024 | The American Lawyer

Weil Gotshal Shutters Beijing and Mulls Shanghai Closure

Weil joins a growing line of top U.S. law firms that have closed offices in mainland China as the fractious geopolitical relationship between the U.S. and China and the prolonged market downturn force the world's top-performing law firms to reconsider their investments in China.
3 minute read
March 27, 2024 | Law.com

Weil Gotshal Shutters Beijing and Mulls Shanghai Closure

Weil joins a growing line of top U.S. law firms that have closed offices in mainland China as the fractious geopolitical relationship between the U.S. and China and the prolonged market downturn force the world's top-performing law firms to reconsider their investments in China.
3 minute read
Regeneron Pharmaceuticals Inc. v. Novartis Pharma AG
Publication Date: 2024-03-26
Practice Area: Antitrust | Business Torts
Industry: Pharmaceuticals
Court: U.S. Court of Appeals for the Second Circuit
Judge: Circuit Judge Barrington D. Parker
Attorneys:
For plaintiff: For Plaintiff-Appellant: Joshua Halpern, Elizabeth S. Weiswasser, Eric S. Hochstadt, & Anish R. Desai, on the brief, Adam Banks, Weil, Gotshal & Manges LLP, New York, NY & Washington, D.C.
For defendant: For Defendants-Appellees Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corp.: Ian Simmons, Lisa Pensabene, Stephen J. McIntyre, & Melissa C. Cassel, on the brief, William Jay, O'Melveny & Myers LLP, Washington, D.C., New York, NY, Los Angeles, CA & San Francisco, CA. Benjamin T. Horton & Julianne M. Hartzell, on the brief, Marshall Gerstein & Borun LLP, Chicago, IL, for Defendant-Appellee Vetter Pharma International GmbH. Anisha S. Dasgupta & Joel Marcus, on the brief, Matthew M. Hoffman, Federal Trade Commission, Washington, D.C., and Jonathan S. Kanter, Daniel E. Haar, Nickolai G. Levin, & Andrew N. DeLaney, on the brief, United States Department of Justice, Antitrust Division, Washington, D.C., Amici Curiae in Support of Neither Party.
Case number: 22-0427-cv

Anti-VEGF Medications in Vials, Pre-Filled Syringes Compete in Different Product Markets

March 25, 2024 | The American Lawyer

The Law Firms and Lawyers That Benefit Most From Private Equity Designation

An in-depth investigation featuring interviews with a wide range of market leaders has shown the law firms and lawyers that frequently get designated mandates on private equity transactions in the UK.
5 minute read
March 20, 2024 | The American Lawyer

Simpson Thacher Swoops For Weil Gotshal Partner Duo in the UK

The infrastructure moves are the latest additions to Simpson Thacher's London base and the latest departures from Weil Gotshal's.
3 minute read
March 18, 2024 | The American Lawyer

Deal Watch: Big Energy and Pharma Deals Continue to Drive M&A

Five of the six announced deals over $1 billion in the last week occurred in either the life sciences or energy sector.
10 minute read
March 18, 2024 | The American Lawyer

Kirkland Crosses $7B Mark, With Steady And Countercyclical Business Drivers

The firm continued to improve its profit margin, as average PEP rose nearly 6% to $7.955 million, according to American Lawyer reporting.
5 minute read
March 14, 2024 | New York Law Journal

A 'True Visionary': Ira Millstein, Longtime Weil Partner and Corporate Governance 'Guru,' Dies at 97 

While Ira Millstein may be credited as a consequential figure for American corporate life in the latter half of the 20th century, he may be remembered just as well for his work in the public sphere.
6 minute read

TRENDING STORIES

    Resources